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Synergism between Porcine Reproductive and Respiratory
Abstract
This study was conducted to investigate the effects of exposure to porcine reproductive and respiratory
syndrome virus, Salmonella choleraesuis, and stress on young swine. Five-week-old segregated early weaned
pigs were randomly assigned to one of eight treatments consisting of all possible combinations of three
factors: S. choleraesuis (SC) on day zero, porcine reproductive and respiratory syndrome virus (PRRSV) on
day three, and dexamethasone (DEX) on days three to seven. DEX was used as a proxy for stress. Treatment
differences were seen in performance parameters, levels and duration of SC shedding, level and distribution of
SC in tissues, clinical disease, and mortality. The results of this study provided evidence to support field
observations that clinical outbreaks of PRRS are the result of interactions among concurrent infections and
stressors.
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Summary and Implications
     This study was conducted to investigate the effects of
exposure to porcine reproductive and respiratory syndrome
virus, Salmonella choleraesuis, and stress on young swine.
Five-week-old segregated early weaned pigs were randomly
assigned to one of eight treatments consisting of all possible
combinations of three factors: S. choleraesuis (SC) on day
zero, porcine reproductive and respiratory syndrome virus
(PRRSV) on day three, and dexamethasone (DEX) on days
three to seven. DEX was used as a proxy for stress.
     Treatment differences were seen in performance
parameters, levels and duration of SC shedding, level and
distribution of SC in tissues, clinical disease, and mortality.
The results of this study provided evidence to support field
observations that clinical outbreaks of PRRS are the result
of interactions among concurrent infections and stressors.
Introduction
      Porcine reproductive and respiratory syndrome virus
(PRRSV) and Salmonella choleraesuis (SC) are important
components of the swine respiratory disease complex. The
recognition of SC as an important and common cause of
swine respiratory disease and the emergence of PRRS as a
new swine disease have both occurred only relatively
recently.
          Although respiratory disease is a major clinical
component of PRRS in field cases1, it has been difficult to
produce respiratory disease in pigs in the research
environment simply by exposure to PRRSV. It has been
postulated that this may be due to low pig density, ideal
housing conditions, and the absence of concurrent bacterial
infections in the research setting.2
    Pigs subclinically infected with SC are considered the
most common source of infection to nave herds. Like
PRRS, it is not clear why and how subclinical infections are
triggered to become acute outbreaks of disease. It has been
suggested that a variety of stressors, including the presence
of concurrent viral infections, may lead to clinical outbreaks
of salmonellosis.3  On two Midwestern farms, nursery
mortality due to salmonellosis reportedly increased
following herd outbreaks of PRRS.4  This led the authors to
suggest that concurrent PRRSV infection may serve to
provoke clinical salmonellosis. The work reported here was
intended to explore these issues.  Specifically, our objective
was to investigate the interactive effects of exposure to
PRRSV, SC, and stress on growth performance and disease
in young swine.
Materials and Methods
Experimental Animals and Design
     Two replicate trials were conducted. In each trial, 5-
week-old segregated, medicated, and early weaned pigs
were divided into eight treatment groups (see Table 1). Each
treatment group was a different combination of three
factors:  inoculation with SC on day zero, inoculation with
PRRSV on day three, and treatment with dexamethasone
(DEX) at a rate of 2 mg/kg on days three to seven. DEX was
used as a chemical proxy for stress. Use of isolation rooms
and strict biosecurity measures, including showering by
caretakers and investigators between rooms, were
maintained to prevent transmission of infectious agents
between groups of pigs.
Bacteria and Virus
     S. choleraesuis strain 3246pp5 and PRRSV isolate ISU-P
(ATCC VR 2402) were used in these experiments.
According to the treatment assigned to the group, pigs were
intranasally challenged with 1.0 ml of 106 CFU/ml of SC
and/or 1.0 ml of 106.7 TCID50/ml PRRSV inoculum.
Biological samples and variables
     A single investigator evaluated the health status of the
pigs once daily over the course of the experiment. Using
minimal restraint, rectal temperatures of the pigs were
recorded once daily from day zero through day 14 of the
experiment. Body weights of the pigs were determined on
days zero and 21 of the trials. Feces, nasal swabs, and tonsil
swabs were collected on days 0, 3, 7, 10, 14, 17, and 21 for
qualitative bacteriological culture. Fecal samples were also
submitted for quantitative bacteriological culture. Samples
of tonsil, lung, liver, spleen, middle ileum, ileocolic
junction, cecum, cecal contents, colon, and mesenteric,
brachial, ileocolic, and colonic lymph nodes were
aseptically collected at necropsy on day 21. Samples from
tissues collected from SC inoculated pigs and ileocolic
junction samples from non SC inoculated pigs were
submitted for qualitative and quantitative bacteriological
culture.
Results and Discussion
Clinical evaluations
     Pigs which were dually infected with SC and PRRSV
exhibited clinical signs of disease. Unthriftiness, rough hair
coats, dyspnea, and diarrhea were most prevalent. The PSD
pigs were the most severely affected; in fact, three of the
PSD pigs either died or were euthanized due to the severity
of the disease. The PSD death loss was statistically
significant by a FischerÕs exact test (p=0.010).
Body temperature
     The proportion of pigs within treatment groups which
had fevers was considered a more clinically relevant
measure than mean temperature. Temperatures greater than
the 97.5 percentile temperature (40.06 0C) of all pigs on day
zero were considered abnormal (fever). The results
indicated that the presence of fever was primarily the result
of SC infection, but fever was exacerbated by either PRRSV
or DEX in SC-infected pigs.
Body weight
     Both percentage increase in body weight (IBW) and
average daily gain (ADG) were affected by treatment (Table
2). The relatively small numbers in treatment groups made it
difficult to form conclusions, but suggested trends. It should
be noted that the pigs which died, all from group PSD, were
excluded from the analysis. At the time of death all three
pigs weighed less than their day zero body weight.
Therefore, the values for the PSD group were biased upward
by the exclusion of the most severely affected pigs. DEX in
combination with PRRSV, SC, or both had the lowest
values for both parameters. The overall trends suggested
that growth performance was most severely affected by
pathogens in conjunction with stress; infection alone did not
greatly affect growth performance.
Fecal quantitative bacteriology
     Significant differences between treatments (p=0.0099)
were shown by analysis of variance for repeated measures
of SC levels in fecal samples. The level of SC in fecal
samples was measured by determining the most probable
number (MPN) of SC per gram of feces. The mean of the
log10 MPN/g feces of the PSD group was significantly
greater (p<0.05, DuncanÕs Multiple Range Test) than the
NSN group on days 7, 10, 14, and 21; the PSN group on
days 10 and 14; and the NSD group on day 10.
     Since the clinical severity of salmonellosis is known to
be dose-dependent, prolonged and elevated shedding of SC
by dual (NSD, PSN) and triple (PSD) treatment groups
suggested the possibility that disease outbreaks in the field
may be the result of high dose exposures of susceptible pigs
from stressed and/or PRRSV-infected herdmates.
Fecal, tonsil, nasal qualitative bacteriology
     For this report, qualitative bacteriology results were
consolidated to determine if there were differences among
groups in duration of SC shedding. The proportion of pigs
within treatment groups that had at least one sample, either
fecal, nasal swab, or tonsil swab, that was positive for SC
are given in Table 3. The proportion of shedders in the
NSD, PSN, and PSD groups were all significantly greater
(p£0.008, Bonferonni Method) than in the NSN group on
day 21. The results indicated that although the PSD had the
most pronounced effect, there were also significant SC-
PRRSV and SC-DEX interactions.
Postmortem tissue bacteriology
     Significant differences were seen among treatment
groups in the proportion of pigs which were SC positive for
particular postmortem tissues. Tissues assayed included
mediastinal lymph node, cecal contents, middle ileum, and
lung. Although the proportions of positive pigs among
treatment groups varied among these four tissues and
differences were not always significant, the relative order of
the treatment groups remained constant. When all tissues
sampled at postmortem were considered, a similar pattern
was seen. PSD had a significantly greater (p£0.008,
Bonferroni Method) proportion than the other groups. The
NSD and PSN groups were intermediate and similar to each
other. The NSN group had the smallest proportion of
positive tissues. Further, the mean log10 MPN/g of cecal
contents of PSD pigs was significantly greater (p<0.05,
DuncanÕs Multiple Range Test) than the other groups. Once
again, the results indicate the PSD pigs, and to a lesser
degree the NSD and PSN pigs, were less able to  respond to
SC infection resulting in a greater distribution and level of
SC in tissues.
Summary
     Treatment differences were seen on ADG, IBW, levels
and duration of SC shedding, level and distribution of SC in
tissues, morbidity, and mortality. Although the number of
pigs per group limited our ability to statistically differentiate
treatment effects for some parameters, a consistent pattern
was seen. Pigs in the PSD treatment group were the most
adversely affected, indicating a high degree of synergism
among these three factors. Pigs in two-factor treatment
groups (PSN, NSD) were affected, but to a lesser extent.
The results of this study provided evidence to support field
observations that clinical outbreaks of PRRS are the result
of interactions among concurrent infections and stressors.
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Table 1. Eight treatment groups derived from all combinations of S. choleraesuis (SC), porcine
reproductive and respiratory syndrome virus (PRRSV), and dexamethasone (DEX).
Treatment Groups PSD PSN NSD NSN PND PNN NND NNN
SC on day 0 + + + +
PRRSV on day 3 + + + +
DEX on days 3 - 7 + + + +
Pigs per group (n) 7 7 6 7 6 7 7 7
Table 2. Increase in body weight (IBW) and average daily gain (ADG) of pigs surviving to day 21.  Mean
IBW or ADG values within a column with the same superscript are not statistically significantly
different (p<0.05) using DuncanÕs Multiple Range Test.
Treatment n Mean IBW Treatment n Mean ADG
NSN 7 79.23a NNN 7 0.393a
NNN 7 79.04a NND 7 0.390a
NND 7 74.00a NSN 7 0.325a,b
PNN 7 73.41a PSN 7 0.278b,c
PSN 7 66.66a PNN 7 0.261b,c
PSD* 4 63.43a,b PSD* 4 0.257b,c
NSD 6 56.10a,b NSD 6 0.247b,c
PND 6 42.01b PND 6 0.177c
*Excludes three pigs which died on days 10, 12, and 17.
Table 3. Proportion of pigs within treatment groups which had at least one fecal sample, tonsil swab, or
nasal swab positive for S. choleraesuis.  Treatments within a column with the same superscript
are not significantly different at p£0.008 using Bonferroni Method.
Treatment Day 3 Day 7 Day 10 Day 14 Day 21
PSD 100.00a 100.00a 100.00a 100.00a 100.00a
NSD 83.33a 100.00a 100.00a 100.00a 66.67a
PSN 71.43a 100.00a 100.00a 71.43a 57.14a
NSN 71.43a 85.71a 85.71a 57.14a 0.00b
